Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket, with all three conditions met. Let's analyze the transcript. Key points: The company is BellRing Brands, maker of Premier Protein and Dymatize. They have been capacity constrained for shakes. They have added co-manufacturers and a greenfield facility (Michael Foods) starting up in December. They are ramping production. They have not restarted meaningful marketing and promotion on shakes due to capacity constraints. They plan to restart promotions in Q2 and marketing in Q4 of fiscal '24. They are paying for capacity expansion, but that is capital investment, not necessarily a current cost landing in results. However, they mention "we still haven't restarted meaningful marketing and promotion" - that implies they are not spending on marketing, so they are not paying for that. They are paying for production scale-up? But they are selling as much as they can produce. The waiting period is about capacity constraints limiting their ability to market and promote. They are bearing the cost of not marketing? That is an opportunity cost, not a cash cost. They are also building inventory? They mention "we add weeks of shake supply" in fiscal '24, which will increase working capital. That is a cost they are bearing now for future benefit. They also have accelerated amortization for PowerBar discontinuation, but that is a one-time noncash charge, not a waiting period. Let's read carefully. Darcy: "We still have work to do, but are well positioned for a strong '24 and beyond." They talk about production growth, adding co-mans, Michael Foods starting in December. They say "There will be a much larger contributor to our second half of fiscal '24 and beyond." So they are waiting for that capacity to come online. They also say: "We plan to step up marketing on shakes in Q4, which is when we expect to hit our target weeks of supply." So they are waiting to hit target inventory levels before marketing. They are currently paying for? They are paying for the capacity expansion? That is capital expenditure, not necessarily in operating results. But they mention working capital increase: "In fiscal '24, our net working capital growth will moderately exceed our net sales growth rate as we add weeks of shake supply.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.